Koshinski Asset Management
AVNS icon

Koshinski Asset Management’s Avanos Medical AVNS Stock Holding History

Koshinski Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$3.35K – 676
2022
Q1 		$3.35K Buy
+100
New +$3.22K ﹤0.01% 1860

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Koshinski Asset Management's AVNS Position: Q2 2022 in Review

Koshinski Asset Management sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 100 shares — an estimated $3.35K sold.

Koshinski Asset Management first reported a position in AVNS in Q1 2022 and held it in 1 quarter. The position peaked at $3.35K in Q1 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Koshinski Asset Management reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 100 Avanos Medical shares in Q2 2022, an estimated $3.35K.
  • Koshinski Asset Management first reported a position in Avanos Medical in Q1 2022 and held it in 1 quarter.
  • Koshinski Asset Management's Avanos Medical position peaked at $3.35K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.